After-Hours Stock Movers:

ZoomInfo Technologies Inc. (NASDAQ: ZI) 17% LOWER; reported Q2 EPS of $0.26, $0.03 better than the analyst estimate of $0.23. Revenue for the quarter came in at $308.6 million versus the consensus estimate of $310.94 million. Announces $500 million Share Repurchase Program ZoomInfo Technologies Inc. sees Q3 2023 EPS of $0.24-$0.25, versus the consensus of $0.25. ZoomInfo Technologies Inc. sees Q3 2023 revenue of $309-312 million, versus the consensus of $325.8 million. ZoomInfo Technologies Inc. sees FY2023 EPS of $0.99-$1.00, versus the consensus of $1.00. ZoomInfo Technologies Inc. sees FY2023 revenue of $1.225-1.235 billion, versus the consensus of $1.28 billion.

Harmonic (NASDAQ: HLIT) 15% LOWER; reported Q2 EPS of $0.12, $0.01 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $156 million versus the consensus estimate of $167.52 million. Harmonic sees Q3 2023 EPS of ($0.02)-$0.02, versus the consensus of $0.19. Harmonic sees Q3 2023 revenue of $125-140 million, versus the consensus of $188.6 million. Harmonic sees FY2023 EPS of $0.38-$0.52, versus the consensus of $0.69. Harmonic sees FY2023 revenue of $620-660 million, versus the consensus of $723.2 million.

Arista Networks (NYSE: ANET) 10% HIGHER; reported Q2 EPS of $1.58, $0.14 better than the analyst estimate of $1.44. Revenue for the quarter came in at $1.46 billion versus the consensus estimate of $1.38 billion. Arista Networks sees Q3 2023 revenue of $1.45-1.5 billion, versus the consensus of $1.391 billion.

Emergent BioSolutions Inc. (NYSE: EBS) 8% HIGHER; announced today that it was awarded a 10-year contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), valued at up to a maximum of $704 million, for advanced development, manufacturing scale-up, and procurement of Ebanga (ansuvimab-zykl), a licensed treatment for Ebola virus disease (EVD).

Trex (NYSE: TREX) 5% HIGHER; reported Q2 EPS of $0.71, $0.17 better than the analyst estimate of $0.54. Revenue for the quarter came in at $357 million versus the consensus estimate of $318.89 million. Trex sees Q3 2023 revenue of $280-290 million, versus the consensus of $264.22 million. Trex sees FY2023 revenue of $1.04-1.06 billion, versus the consensus of $1.05 billion.

Yum China (NYSE: YUMC) 4% LOWER; reported Q2 EPS of $0.47, $0.01 better than the analyst estimate of $0.46. Revenue for the quarter came in at $2.65 billion versus the consensus estimate of $2.72 billion.

Avis Budget Group (NASDAQ: CAR) 2% HIGHER; reported Q2 EPS of $11.01, $1.57 better than the analyst estimate of $9.44. Revenue for the quarter came in at $3.12 billion versus the consensus estimate of $3.21 billion.